Skip to main content
SpringerLink
Log in

Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Heart rate modulation therapy using ivabradine reduces mortality and morbidity in patients with systolic heart failure, whereas too reduced heart rate seems to worsen the clinical outcome. The optimal heart rate during heart rate modulation therapy remains unknown. Consecutive patients with left ventricular ejection fraction < 50% who received echocardiographic assessments and simultaneous heart rate measurements were retrospectively investigated. Theoretically ideal heart rate was calculated using a previously proposed formula: 93 − 0.13 × (deceleration time [msec]). Impacts of heart rate on the 1-year echocardiographic left ventricular reverse remodeling were compared among the three groups stratified by the heart rate status: optimal heart rate group (within 10 bpm of ideal heart rate), below-optimal heart rate group (< 10 bpm of ideal heart rate), and above-optimal heart rate group (> 10 bpm of ideal heart rate). A total of 75 patients (70 years old, 60 men) were included. There were no significant differences in the baseline characteristics among the three groups, except for the higher prevalence of tolvaptan use and higher plasma B-type natriuretic peptide level in the below-optimal heart rate group. Left ventricular end-diastolic diameter (from 55 to 54) and left ventricular ejection fraction (from 39 to 46) improved significantly only in the optimal heart rate group at 1-year follow-up (p < 0.05 for both). Optimal heart rate, which was calculated using a formula consisting of deceleration time, was associated with cardiac reverse remodeling in patients with systolic heart failure. Prospective study to investigate the implication of deceleration time-guided aggressive heart rate optimization is the next concern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators SHIFT (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885

    Article  CAS  Google Scholar 

  2. Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR (2017) The clinical use of ivabradine. J Am Coll Cardiol 70(14):1777–1784

    Article  Google Scholar 

  3. Fiuzat M, Wojdyla D, Pina I, Adams K, Whellan D, O’Connor CM (2016) Heart rate or beta-blocker dose? Association with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION trial. JACC Heart Fail 4(2):109–115

    Article  Google Scholar 

  4. Izumida T, Imamura T, Nakamura M, Fukuda N, Kinugawa K (2020) How to consider target heart rate in patients with systolic heart failure. ESC Heart Fail 7(5):3231–3234

    Article  Google Scholar 

  5. Gardin JM, Adams DB, Douglas PS, Feigenbaum H, Forst DH, Fraser AG, Grayburn PA, Katz AS, Keller AM, Kerber RE, Khandheria BK, Klein AL, Lang RM, Pierard LA, Quinones MA, Schnittger I, American Society of Echocardiography (2002) Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography’s Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 15(3):275–290

    Article  Google Scholar 

  6. Dandel M, Hetzer R (2021) Ventricular systolic dysfunction with and without altered myocardial contractility: clinical value of echocardiography for diagnosis and therapeutic decision-making. Int J Cardiol 327:236–250

    Article  Google Scholar 

  7. Koitabashi N, Kass DA (2011) Reverse remodeling in heart failure–mechanisms and therapeutic opportunities. Nat Rev Cardiol 9(3):147–157

    Article  Google Scholar 

  8. Maurer MS, Sackner-Bernstein JD, El-Khoury Rumbarger L, Yushak M, King DL, Burkhoff D (2009) Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure. Circ Heart Fail 2(3):189–196

    Article  CAS  Google Scholar 

  9. Chung CS, Afonso L (2016) Heart rate is an important consideration for cardiac imaging of diastolic function. JACC Cardiovasc Imaging 9(6):756–758

    Article  Google Scholar 

  10. Chung CS, Kovács SJ (2006) Consequences of increasing heart rate on deceleration time, the velocity-time integral, and E/A. Am J Cardiol 97(1):130–136

    Article  Google Scholar 

  11. Yamanaka T, Onishi K, Tanabe M, Dohi K, Funabiki-Yamanaka K, Fujimoto N, Kurita T, Tanigawa T, Kitamura T, Ito M, Nobori T, Nakano T (2006) Force- and relaxation-frequency relations in patients with diastolic heart failure. Am Heart J 152(5):966.e1–7

    Article  Google Scholar 

  12. Dandel M, Hetzer R (2018) Recovery of failing hearts by mechanical unloading: pathophysiologic insights and clinical relevance. Am Heart J 206:30–50

    Article  Google Scholar 

  13. Fu X, Segiser A, Carrel TP, Tevaearai Stahel HT, Most H (2016) Rat heterotopic heart transplantation model to investigate unloading-induced myocardial remodeling. Front Cardiovasc Med 3:34

    Article  Google Scholar 

  14. Takada T, Sakata Y, Miyata S, Takahashi J, Nochioka K, Miura M, Tadaki S, Shimokawa H, CHART-2 Investigators (2014) Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study. Eur J Heart Fail 16(3):309–316

    Article  Google Scholar 

  15. DeVore AD, Schulte PJ, Mentz RJ, Hardy NC, Kelly JP, Velazquez EJ, Maya JF, Kielhorn A, Patel HK, Reed SD, Hernandez AF (2016) Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs. Am J Cardiol 117(6):946–951

    Article  Google Scholar 

  16. Li SJ, Sartipy U, Lund LH, Dahlström U, Adiels M, Petzold M, Fu M (2015) Prognostic Significance of resting heart rate and use of beta-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry. Circ Heart Fail 8(5):871–879

    Article  CAS  Google Scholar 

  17. Ferrari R, Fox K (2016) Heart rate reduction in coronary artery disease and heart failure. Nat Rev Cardiol 13(8):493–501

    Article  Google Scholar 

  18. Nikolovska Vukadinović A, Vukadinović D, Borer J, Cowie M, Komajda M, Lainscak M, Swedberg K, Böhm M (2017) Heart rate and its reduction in chronic heart failure and beyond. Eur J Heart Fail 19(10):1230–1241

    Article  Google Scholar 

  19. Ibrahim NE, Gaggin HK, Turchin A, Patel HK, Song Y, Trebnick A, Doros G, Maya JF, Cannon CP, Januzzi JL (2019) Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction. Eur Heart J Cardiovasc Pharmacother 5(1):3–11

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

TI receives grant support from JSPS KAKENHI: JP20K17143.

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama, 930-0194, Japan

    Toshihide Izumida, Teruhiko Imamura, Yohei Ueno, Shuhei Tanaka, Naoya Kataoka, Makiko Nakamura & Koichiro Kinugawa

Authors
  1. Toshihide Izumida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teruhiko Imamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yohei Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuhei Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naoya Kataoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Makiko Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Koichiro Kinugawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Teruhiko Imamura.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 28 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Izumida, T., Imamura, T., Ueno, Y. et al. Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure. Heart Vessels 36, 1688–1693 (2021). https://doi.org/10.1007/s00380-021-01864-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-01864-5

Keywords

Search

Navigation